Roghayeh Akbari, Mohsen Vakili Sadeghi
*1 Department of Internal Medicine, Babol University of Medical Sciences, Babol, Iran
Abstract
Polycythemia vera (PV) is a clonal over proliferation of hematopoietic stem cells, which increases red blood cell (RBC) mass and hematocrit, and is frequently accompanied with leukocytosis, thrombocytosis, or both. Few cases of renal involvement of PV have been reported to date. We present a case of PV based on JAK2 (Janus kinase 2) mutation that did not need any treatment after unrelated kidney transplantation. According to the rarity of kidney transplantation in PV, more clinical evidence is needed to determine the frequency of its improvement after transplantation
Implication for health policy/practice/research/medical education:
Few cases of renal involvement of polycythemia vera have been reported to date. We present a case of polycythemia vera based on JAK2 (Janus kinase 2) mutation that did not need any treatment after unrelated kidney transplantation. According to the rarity of kidney transplantation in polycythemia vera, more clinical evidence is needed to determine the frequency of its improvement after transplantation.
Please cite this paper as: Akbari R, Sadeghi MV. Kidney transplantation in a patient with polycythemia vera. J Nephropharmacol. 2017;x(x):x-x. DOI: 10.15171/npj.2017.19